Related Experiment Video

Updated: Aug 10, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Monoclonal antibodies: new agents for cancer detection and targeted therapy

R W Baldwin1, V S Byers

  • 1Cancer Research Campaign Laboratories, University of Nottingham, U.K.

Cancer Detection and Prevention
|January 1, 1991
PubMed

Insights

Monoclonal antibodies offer a revolutionary approach to cancer diagnostics and therapeutics. Advances in hybridoma technology now enable large-scale production for effective cancer detection and treatment.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Antibodies targeting cancer cell markers are crucial for diagnostics and therapeutics.
  • Previous antibody production methods were limited, hindering clinical success.
  • The development of hybridoma technology marked a significant breakthrough.

Purpose of the Study:

  • To highlight the importance of monoclonal antibodies in cancer research.
  • To explain the technological advancements enabling their production.
  • To underscore their potential in cancer detection and therapy.

Main Methods:

  • Fusion of antibody-producing cells (lymphocytes) with myeloma cells to create hybridomas.
  • Culturing hybridomas for continuous secretion of specific antibodies.
  • Scaling up production of monoclonal antibodies for clinical applications.

Main Results:

  • Hybridomas provide a consistent and reliable source of specific antibodies.
  • Monoclonal antibodies can be produced reproducibly on a large scale.
  • This technology overcomes previous limitations in antibody production.

Conclusions:

  • Monoclonal antibodies are vital tools in modern oncology.
  • Hybridoma technology has revolutionized the field of antibody production.
  • Large-scale manufacturing enables widespread use in cancer detection and therapy.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.